Impact of between-tissue differences on pan-cancer predictions of drug sensitivity.

Abstract excerpt

Increased availability of drug response and genomics data for many tumor cell lines has accelerated the development of pan-cancer prediction models of drug response. However, it is unclear how much between-tissue differences in drug response and molecular characteristics may contribute to pan-cancer predictions. Also unknown is whether the performance of pan-cancer models could vary by cancer type. Here, we built...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Area Under Curve
• Share to Drug Screening Assays, Antitumor
• Share to Enzyme Inhibitors